martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 1, 2026

Smartphones Market Worth USD 739.23 Billion by 2031 with Android Segment Holding 69.21% Market Share and AI Adoption Accelerates Growth, Reports Mordor Intelligence

View original at globenewswire.com
Smartphones Market Worth USD 739.23 Billion by 2031 with Android Segment Holding 69.21% Market Share and AI Adoption Accelerates Growth, Reports Mordor Intelligence Hyderabad, India, June 01, 2026 (GLOBE NEWSWIRE) -- Mordor Intelligence has published a new report on the smartphones market, providing a comprehensive ana…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Android segment holds 69.21% market share in the global smartphones market.

    60% confidence
  • As smartphone market dynamics continue to evolve across regions and price segments, decision-makers require analysis grounded in consistently applied research standards and transparent evaluation of market developments.

    60% confidence
  • The Used and Refurbished Smartphone Market is expected to reach USD 69.66 billion in 2026 and grow to USD 96.99 billion by 2031, registering a CAGR of 6.84% during the forecast period.

    60% confidence
  • The smartphones market size is expected to grow from USD 609.29 billion in 2026 and is forecast to reach USD 739.23 billion by 2031, registering a CAGR of 3.94% during 2026-2031.

    60% confidence
  • Geopolitics and tariffs are shifting SKUs and raising logistics complexity as a market restraint.

    60% confidence
  • Smartphone vendors are focusing on foldable designs, on-device AI functionality, and sustainable manufacturing practices to strengthen their competitive positioning.

    60% confidence
  • Advanced AI capabilities are becoming a key factor influencing smartphone purchases, with consumers attracted to smarter personalization, improved photography, real-time language assistance, and productivity tools on the handset.

    60% confidence
  • Increasing 5G adoption, growing consumer demand for premium devices, and expansion of digital ecosystems are supporting long-term smartphone market growth.

    60% confidence
  • Asia-Pacific remains a key hub for the smartphones market, supported by strong consumer demand, expanding local manufacturing capabilities, and ongoing investments in mobile technology.

    60% confidence
  • Used or refurbished smartphone growth is cannibalizing new device demand, acting as a market restraint.

    60% confidence
  • The growing availability of budget-friendly 5G smartphones is helping accelerate adoption across developing markets.

    60% confidence
  • The Foldable Smartphone Market is expected to reach USD 38.68 billion in 2026 and grow to USD 110.19 billion by 2031, registering a CAGR of 23.29% during the forecast period.

    60% confidence
  • Memory supply tightness lifts bill-of-materials costs, pressuring low-end Android devices.

    60% confidence
  • The Middle East is witnessing increasing demand for advanced smartphones, driven by digital transformation initiatives and growing interest in premium mobile experiences.

    60% confidence
  • The Middle East and Africa Smartphones Market is projected to reach USD 33.95 billion in 2026 and expand to USD 50.14 billion by 2031, growing at a CAGR of 8.12%.

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com